| |
|
|
|
Soleno Therapeutics Inc.  
|
|
2.13 0.1 (0.05%) |
09-21 16:00 |
|
Open: |
2.04 |
Pre close: |
2.03 |
Target:
|
2.59 
|
|
High: |
2.2 |
Low: |
2.03 |
Resistance:
|
2.22
2.46
|
|
Volume: |
20,087 |
Market Cap: |
46M |
Support:
|
1.82
1.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.05
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
2.09 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
2.28 |
Stochastic Oscillator |
%K(14,3):
|
42.91 |
|
MA(250): |
2.04 |
%D(3): |
38.49 |
|
Average Volume(K) |
3-Month: |
3873
|
52-Week |
High:
|
3.60 |
|
10-Days: |
2539 |
Low: |
1.32 |
|
RSI |
RSI(14):
|
47.65 |
Change(%): |
-25.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-93.7 |
Shares Out. (M) |
21.41 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-62.7 |
Shares Float (M) |
20.39 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
35.00 |
|
Forward EPS |
-0.791 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
82 |
|
Book Value (p.s.) |
2.680 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.79 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.04 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-2.36 |
P/CF |
-4.54 |
|
|
|
|
|
|
